https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Astegolimab Reduces COPD Exacerbations in Clinical Trials

Astegolimab Reduces COPD Exacerbations in Clinical Trials

Astegolimab shows promise in reducing chronic obstructive pulmonary disease (COPD) exacerbations, offering hope for improved management of this debilitating lung disease.

administrator

Related Articles